Skip to Content

Trillium Therapeutics

TRIL

Buy $TRIL at eToro
Rank 3660
Country USA
Exchange NASDAQ
Currency USD
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 100 CAMBRIDGEPARK DRIVE, SUITE 510, CAMBRIDGE, MA, CANADA

Trillium Therapeutics - Key figures

Market cap 1.94 Billion
Revenue 43 Thousand
Profit 148 Thousand
P/E Ratio No information
P/s Ratio 45025.77
Buy $TRIL at eToro

Trillium Therapeutics - Description

Trillium Therapeutics Inc., a clinical-stage immuno-oncology company, develops therapies for the treatment of cancer.

The company is headquartered in Mississauga, Canada.